Analysts/Institutional Investor Meet/Con. Call Updates

04th November, 2026 The Corporate Relationship Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Dalal Street, Bandra East, Mumbai 400 001. Mumbai 400 051. Scrip Code: 539523 Scrip Symbol: ALKEM Sub: Intimation of Conference Call on Q2FY27 and H1FY27 financial results Dear Sir(s) / Madam, With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q2FY27 and H1FY27 financial results will be held on Thursday, November 12, 2026 at 04.30 p.m. Please find attached herewith the conference call details. Kindly take note of the same. Sincerely, For Alkem Laboratories Limited Manish Narang President – Legal, Company Secretary & Compliance Officer Invite for Q2FY27 & H1FY27 Conference Call at 4.30 pm IST, November 12, 2026 Mumbai, November 04, 2026: Alkem Laboratories Ltd. (NSE: ALKEM, BSE: 539523, Bloomberg: ALKEM.IN, Reuters: ALKE.NS) will hold a conference call for investors and analysts on Thursday, November 12, 2026, from 4:30 pm to 5:30 pm IST to discuss its Q2 and H1FY27 financial results. The call will follow the announcement of the Company’s Q2 and H1FY27 financial results on Thursday, November 12, 2026. Alkem Laboratories Ltd. will be represented on the call by: Mr. Sandeep Singh – Managing Director Dr. Amrut Naik – Chief Executive Officer Mr. Dishant Hitesh Doshi – Deputy Chief Financial Officer Motilal Oswal Securities Ltd. will host the call. Details of the Conference call are as follows Time 4:30 pm IST (GMT + 5:30) on Thursday, November 12, 2026. Dial in Details India +91 22 6280 1149 / +91 22 7115 8050 International Toll-Free USA 1 866 746 2133 UK 0 808 101 1573 Singapore 800 101 2045 Hong Kong 800 964 448 Express Join with Diamond Pass https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=5192390&linkSecurityStr ing=2e6b8253ae You are requested to dial in 10 minutes ahead of the scheduled start time. Smeett Jain / Richa K. Sinari Tushar Manudhane Investor Relations / Media Alkem Institutional Research Analyst - Healthcare Motilal Laboratories Ltd. Oswal Securities Ltd. Mobile: +91 91522 29327 / 98201 84988 Tel.: +91 22 6129 1536 / +91 82911 38039 Tel.: +91 22 3982 9999 Ext: 9447 E-mail: Tushar.Manudhane@motilaloswal.com E-mail: smeett.jain@alkem.com richa.sinari@alkem.com